• Investing
  • Stock
Round Table Thoughts
  • Economy
  • Editor’s Pick
Home Editor's Pick Walgreens CEO Roz Brewer steps down after more than two years in the role
Editor's Pick

Walgreens CEO Roz Brewer steps down after more than two years in the role

by September 6, 2023
by September 6, 2023 0 comment
Share
0
FacebookTwitterPinterestWhatsapp

Walgreens Boots Alliance said Friday that Roz Brewer had stepped down as the company’s chief executive.

She also left the company’s board, effective Thursday. The decision was mutual, according to a news release.

Shares of Walgreens were effectively flat in premarket trading.

Ginger Graham, the lead independent director and a healthcare industry veteran, will work as interim chief while the company searches for a replacement. Graham is a veteran of the healthcare industry.

Brewer has agreed to continue advising the company until it selects a permanent CEO. She didn’t immediately return requests for comment.

“Our Board and leadership team will intensify our focus on creating value for our customers and our shareholders while we advance the search for a successor with deep healthcare experience to lead in today’s dynamic environment,” said Stefano Pessina, Walgreens’ executive chairman.

Brewer and Walgreens were in a rough patch leading up to Friday’s announcement. Walgreens shares are down more than 32% this year as of Thursday’s close, as the company has struggled with a drop in demand for Covid testing and vaccines. It’s also seen front-end retail sales for items like toothpaste and shampoo consistently fall as consumers go to competitors like Walmart and Amazon for those everyday necessities, which can be ordered online and delivered within a couple of days.

In June, the company reported fiscal third-quarter earnings that missed Wall Street expectations for the first time since July 2020. It also slashed its profit guidance for the year.

However, Covid cases are back on the rise and could prove to be a boon for pharmacy sales. The next Covid boosters are slated to start rolling out in mid-September.

For consumers who may not be interested in another Covid booster, they could still turn to Walgreens for its typical over-the-counter cold and flu products. During its fiscal first quarter ended Nov. 30, an early cold and flu season boosted demand for cough and cold medicine and helped Walgreens offset its losses from a slowdown in vaccine demand.

A retail veteran in a health care world

A veteran of Walmart and Starbucks, Brewer had led Walgreens since March 2021. During her brief tenure, which included a sizable stretch of the Covid pandemic, the company had pursued a transition that would position Walgreens more as a healthcare company than a pharmacy chain.

Walgreens recently acquired Summit Health and primary-care provider VillageMD, which has opened hundreds of total clinics, including some that are adjacent to Walgreens stores.

It also struck a deal with CareCentrix, which coordinates home care for patients after they’re discharged from the hospital, and Shields Health Solutions, a specialty pharmacy company.

Competitor CVS Health Corp has also been leaning into a healthcare strategy. In February, it announced plans to acquire Oak Street Health Inc for about $9.5 billion in cash so it can add primary care to its portfolio of health offerings. Meanwhile, Rite Aid Corp has focused on expanding its pharmacy presence and is now reportedly preparing a bankruptcy filing.

Yet as Walgreens leans deeper into its aspirations to become a health care provider and away from its identity as a drugstore chain, Brewer’s skillset isn’t as aligned with the company’s goals. Prior to her tenure with Walgreens, she served as Starbucks’ operating chief and group president, and previously ran Walmart’s Sam’s Club as its CEO. She’d spent about a decade with Walmart in a series of executive positions.

“The retail side of the business, where Ms. Brewer has much more experience, is simply not an area that Walgreens wants to pursue as a major growth opportunity,” retail analyst and GlobalData managing director Neil Saunders said in an emailed statement.

“All of this must come as a disappointment to Ms. Brewer, but it also means that a different sort of experience is needed to lead the business. It is notable that the interim CEO, Ginger Graham, has a much deeper background in the healthcare and pharma industries,” he added.

More from CNBC

China says the best way to ‘de-risk’ is to restore stability with the U.S. Hollywood studios should cut Netflix out of strike negotiations, Barry Diller says U.S. health officials want to loosen marijuana restrictions. Here’s what it means for the industry

This post appeared first on NBC NEWS
You Might Also Like
  • Aeris to Acquire IoT Business from Ericsson
  • Transforma Insights unveils analysis of which are the leading IoT connectivity providers
  • Listings for Stanley tumblers are still attracting dozens of bids on eBay for hundreds of dollars
  • Consumer confidence pops in the last month of a year that dodged recession forecasts
Share
0
FacebookTwitterPinterestWhatsapp

previous post
Ethics complaints over WI Justice Protasiewicz’s campaign statements rejected
next post
It’s Really All About the Retail Sector Now

You may also like

Home prices soar even higher in February, despite higher mortgage...

May 2, 2024

Federal Reserve holds interest rates steady as consumer confidence improves...

February 1, 2024

Thousands of Southern California hotel workers begin strike

July 3, 2023

U.S. consumer sentiment falls slightly as outlook for inflation worsens

April 16, 2024

Super Bowl ads beckon up to $8 million apiece for...

January 30, 2025

Trump Media shares plunge after company files to issue additional...

April 16, 2024

You have a month left to get your share of...

August 1, 2023

U.S. engine maker facing largest Clean Air Act penalty ever...

December 23, 2023

Valentine’s Day spending on significant others is expected to hit...

January 30, 2024

Vince McMahon settles with SEC over hush money agreements as...

January 11, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Nvidia results spark global chip rally

      May 30, 2025
    • Boeing to resume airplane deliveries to China next month, ramp up Max production, CEO says

      May 29, 2025
    • Nuclear Power Trio: OKLO, SMR, and CCJ in Focus

      May 29, 2025
    • Analyzing SIL, USO, and NVDA: Could These Bullish Patterns Trigger?

      May 29, 2025
    • E.l.f. Beauty to acquire Hailey Bieber skin care brand Rhode in up to $1 billion deal

      May 29, 2025

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be...

      June 27, 2024 2,764 views
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as...

      August 9, 2024 2,470 views
    • 3

      Biden appointee played key role in recruiting Chinese...

      June 25, 2024 2,450 views
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful...

      July 10, 2024 2,429 views
    • 5

      Harris VP pick spent years promoting research facility...

      August 29, 2024 2,307 views

    Categories

    • Economy (7,009)
    • Editor's Pick (2,104)
    • Investing (538)
    • Stock (2,578)

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be revived under new House GOP bill

      June 27, 2024
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as Harris camp blasts ‘lying’ critics

      August 9, 2024
    • 3

      Biden appointee played key role in recruiting Chinese businesses to Delaware: ‘Longtime friends’

      June 25, 2024
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful of Chinese spy threats

      July 10, 2024
    • 5

      Harris VP pick spent years promoting research facility that collaborated with ‘Chinese military company’

      August 29, 2024

    Latest News

    • Nvidia results spark global chip rally

      May 30, 2025
    • Boeing to resume airplane deliveries to China next month, ramp...

      May 29, 2025
    • Nuclear Power Trio: OKLO, SMR, and CCJ in Focus

      May 29, 2025

    Categories

    • Economy (7,009)
    • Editor's Pick (2,104)
    • Investing (538)
    • Stock (2,578)

    Disclaimer: RoundTableThoughts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 RoundTableThoughts.com. All Rights Reserved.

    Round Table Thoughts
    • Investing
    • Stock
    Round Table Thoughts
    • Economy
    • Editor’s Pick

    Read alsox

    Americans got stingier after a pandemic...

    June 29, 2023

    Wholesale inflation rose 0.6% in February,...

    March 15, 2024

    Walmart issues recall of apple juice...

    August 27, 2024
    Sign In

    Keep me signed in until I sign out

    Forgot your password?

    Password Recovery

    A new password will be emailed to you.

    Have received a new password? Login here